Shinva Medical Instrument Co Ltd (600587) — Tangible Net Worth Ratio

Latest as of September 2025: 94.5%

Shinva Medical Instrument Co Ltd (600587) has a Tangible Net Worth Ratio of 94.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥451.47 Million) from net assets (CN¥8.16 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Shinva Medical Instrument Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

94.5%
Tangible equity / total equity

Net Assets (Equity)

CN¥8.16 Billion
CNY

Intangible Assets

CN¥451.47 Million
Goodwill, patents, brand value

Total Assets

CN¥15.08 Billion
CNY

Shinva Medical Instrument Co Ltd Tangible Net Worth Ratio (1999–2024)

This chart shows how Shinva Medical Instrument Co Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 1999 to 2024. As of September 2025, the ratio stands at 94.5%, reflecting net assets of CN¥8.16 Billion with intangible assets of CN¥451.47 Million CNY. See defensive interval ratio of Shinva Medical Instrument Co Ltd to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Shinva Medical Instrument Co Ltd (1999–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Shinva Medical Instrument Co Ltd from 1999 to 2024, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600587 stock market capitalisation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2024 94.1% CN¥7.98 Billion CN¥469.87 Million CN¥15.53 Billion ▲ +0.3 pp
2023 93.8% CN¥7.72 Billion CN¥478.06 Million CN¥15.59 Billion ▲ +2.1 pp
2022 91.7% CN¥5.79 Billion CN¥478.53 Million CN¥12.95 Billion ▲ +0.5 pp
2021 91.2% CN¥5.27 Billion CN¥461.25 Million CN¥11.61 Billion ▲ +2.0 pp
2020 89.2% CN¥4.86 Billion CN¥523.45 Million CN¥11.55 Billion ▲ +1.0 pp
2019 88.3% CN¥4.69 Billion CN¥550.89 Million CN¥11.61 Billion ▲ +3.1 pp
2018 85.1% CN¥4.16 Billion CN¥618.53 Million CN¥12.38 Billion ▲ +0.6 pp
2017 84.6% CN¥4.13 Billion CN¥636.18 Million CN¥12.42 Billion ▲ +0.4 pp
2016 84.2% CN¥4.02 Billion CN¥635.45 Million CN¥11.37 Billion ▼ -2.9 pp
2015 87.0% CN¥3.97 Billion CN¥513.87 Million CN¥9.82 Billion ▲ +0.1 pp
2014 86.9% CN¥3.45 Billion CN¥451.09 Million CN¥8.07 Billion ▼ -2.0 pp
2013 88.9% CN¥2.72 Billion CN¥301.17 Million CN¥5.39 Billion ▼ -2.1 pp
2012 91.0% CN¥1.62 Billion CN¥145.73 Million CN¥3.38 Billion ▼ -0.9 pp
2011 91.9% CN¥871.17 Million CN¥70.53 Million CN¥1.95 Billion ▼ -2.8 pp
2010 94.7% CN¥777.06 Million CN¥41.50 Million CN¥1.49 Billion ▲ +2.8 pp
2009 91.8% CN¥710.12 Million CN¥58.11 Million CN¥1.04 Billion ▲ +0.7 pp
2008 91.2% CN¥656.12 Million CN¥58.04 Million CN¥1.01 Billion ▼ -0.3 pp
2007 91.5% CN¥628.10 Million CN¥53.58 Million CN¥1.01 Billion ▼ -2.8 pp
2006 94.3% CN¥365.69 Million CN¥20.92 Million CN¥842.41 Million ▼ -3.9 pp
2005 98.2% CN¥344.98 Million CN¥6.36 Million CN¥770.96 Million ▼ -0.2 pp
2004 98.3% CN¥328.57 Million CN¥5.48 Million CN¥721.97 Million ▼ 0.0 pp
2003 98.4% CN¥333.97 Million CN¥5.48 Million CN¥580.86 Million ▼ -0.7 pp
2002 99.1% CN¥294.23 Million CN¥2.69 Million CN¥528.82 Million ▲ +1.8 pp
2001 97.3% CN¥90.65 Million CN¥2.46 Million CN¥282.73 Million ▲ +0.9 pp
2000 96.4% CN¥69.69 Million CN¥2.50 Million CN¥181.20 Million ▼ -3.6 pp
1999 100.0% CN¥57.91 Million CN¥0.00 CN¥116.65 Million
pp = percentage points